Abstract:Aminoacyl-tRNA synthetases (aaRSs) are an attractive class of antibacterial drug targets due to their essential roles in protein translation. While most traditional aaRS inhibitors target the binding pockets of substrate amino acids and/or ATP, we recently developed a class of novel tRNA-amino acid dual-site inhibitors including inhibitor 3 ((2S,3R)-2-amino-N-((E)-4-(6,7-dichloro-4-oxoquinazolin-3(4H)-yl)but-2-en-1-yl)-3-hydroxybutanamide) against threonyl-tRNA synthetase (ThrRS). Here, the binding modes and structure-activity relationships (SARs) of these inhibitors were analyzed by the crystal structures of Salmonella enterica ThrRS (SeThrRS) in complex with three of them. Based on the cocrystal structures, twelve quinazolinone-threonine hybrids were designed and synthesized, and their affinities, enzymatic inhibitory activities, and cellular potencies were evaluated. The best derivative 8g achieved a Kd value of 0.40 μM, an IC50 value of 0.50 μM against SeThrRS and MIC values of 16∼32 μg/mL against the tested bacterial strains. The cocrystal structure of the SeThrRS-8g complex revealed that 8g induced a bended conformation for Met332 by forming hydrophobic interactions, which better mimicked the binding of tRNAThr to ThrRS. Moreover, the inhibitory potency of 8g was less impaired than a reported ATP competitive inhibitor at high concentrations of ATP, supporting our hypothesis that tRNA site inhibitors are likely superior to ATP site inhibitors in vivo, where ATP typically reaches millimolar concentrations.

Synthesis and Evaluation of Adenosine Containing 3-Arylfuran-2(5h)-ones As Tyrosyl-Trna Synthetase Inhibitors

Adenosine Analogs As Inhibitors of Tyrosyl-Trna Synthetase: Design, Synthesis and Antibacterial Evaluation.

Synthesis and Evaluation of New Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents Based on a N2-(arylacetyl)glycinanilide Scaffold

Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents: Synthesis, Molecular Docking and Structure-Activity Relationship Analysis of 3-Aryl-4-arylaminofuran-2(5h)-ones

4-Alkoxy-3-arylfuran-2(5h)-ones As Inhibitors of Tyrosyl-Trna Synthetase: Synthesis, Molecular Docking and Antibacterial Evaluation.

3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.

4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5h)-one As Inhibitors of Tyrosyl-Trna Synthase: Synthesis, Molecular Docking and Antibacterial Evaluation

Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.

Metronidazole Containing Pyrazole Derivatives Potently Inhibit Tyrosyl-Trna Synthetase: Design, Synthesis, and Biological Evaluation

Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases

Synthesis and Antibacterial Evaluation of Thiouracil Derivatives Contain-ing 1,2,4-Triazolo[1,5-a]pyrimidine

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

C-7 modified flavonoids as novel tyrosyl-tRNA synthetase inhibitors

Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors

Novel 1,3,4-Oxadiazole Thioether Derivatives Targeting Thymidylate Synthase As Dual Anticancer/antimicrobial Agents.

Synthesis and Bioactivity of A Novel Series of 3,6-Disubstituted 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazoles

Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.

Synthesis and Antimicrobial Evaluation of 5-Aryl-1,2,4-triazole-3-thione Derivatives Containing A Rhodanine Moiety

Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.

Design, synthesis and activity against drug-resistant bacteria evaluation of C-20, C-23 modified 5- O -mycaminosyltylonolide derivatives

Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors